11,192 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Purchased by Vega Investment Solutions

Vega Investment Solutions bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 11,192 shares of the medical device company’s stock, valued at approximately $1,029,000. Cooper Companies makes up approximately 0.8% of Vega Investment Solutions’ portfolio, making the stock its 26th largest position.

Several other institutional investors and hedge funds have also bought and sold shares of COO. Byrne Asset Management LLC bought a new stake in Cooper Companies during the fourth quarter worth about $33,000. OFI Invest Asset Management acquired a new position in Cooper Companies during the fourth quarter worth approximately $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies during the fourth quarter worth approximately $38,000. Covestor Ltd increased its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after buying an additional 120 shares during the last quarter. Finally, Atala Financial Inc acquired a new position in Cooper Companies during the fourth quarter worth approximately $51,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Wednesday. Robert W. Baird lowered their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Piper Sandler reissued an “overweight” rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Thursday. Finally, BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Price Performance

Cooper Companies stock opened at $79.30 on Friday. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The stock’s 50 day moving average is $80.28 and its 200-day moving average is $89.52. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $15.86 billion, a price-to-earnings ratio of 40.67, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.